X, F., S, J., Y, L., Y, G., B, G., J, L., . . . L, Y. (2025). Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors. Journal of Hepatocellular Carcinoma, ume 12(Issue 1), 1069-1082.
Chicago-referens (17:e uppl.)X, Fu, et al. "Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors." Journal of Hepatocellular Carcinoma ume 12, no. Issue 1 (2025): 1069-1082.
MLA-referens (9:e uppl.)X, Fu, et al. "Spleen Volume Dynamics and Survival Outcomes in HCC Patients Undergoing Immune Checkpoint Inhibitors." Journal of Hepatocellular Carcinoma, vol. ume 12, no. Issue 1, 2025, pp. 1069-1082.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.
